Yes. The labour market intelligence study that we did shortly after COVID stated that there are going to be 65,000 unfilled positions in Canada's biotech industry by the year 2029. Those are among three different areas: research and development; industry-agnostic positions, such as HR, marketing and sales; and bioprocessing and biomanufacturing.
This directly affects Canada's defence policy and Canada's health emergency readiness, because, as we saw on COVID, it is the biotech industry that's going to be responsible for the domestic manufacture of vaccines in the face of another pandemic. This is obviously of great concern, not only to the bioeconomy but also for Canadians' health and safety.